Effects of sildenafil a phosphodiesterase 5 inhibitor on rat liver cell key enzymes of gluconeogenesis and glycogenolysis

International Journal of Pharmacology

Volumn 2, Issue 3, 2006, Pages 280-285

  Hoseini, Sheyda ^a   Esmaily, Hadi ^a   Mohammadirad, Azadeh ^a   Abdollahi, Mohammad ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

CAMP; CGMP; Gluconeogenesis; Glycogenolysis; Liver

Indexed keywords

GLUCOSE; GLYCOGEN PHOSPHORYLASE; LIVER ENZYME; NITRIC OXIDE; PHOSPHODIESTERASE V INHIBITOR; PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP); SILDENAFIL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; DRUG MEGADOSE; ENZYME ACTIVITY; ENZYME ANALYSIS; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; GLYCOGENOLYSIS; IN VIVO STUDY; LIVER HOMOGENATE; LIVER PERFUSION; MALE; NONHUMAN; RAT;

EID: 33745751145     PISSN: 18117775     EISSN: 18125700     Source Type: Journal    
DOI: 10.3923/ijp.2006.280.285     Document Type: Article

References (41)

1. Abdollahi, M. and B. Simaiee, 2003. Stimulation by theophylline and sildenafil of rat submandibular secretion of protein, epidermal growth factor and flow rate. Pharmacol. Res., 48: 445-449.
2. Abdollahi, M., F. Fooladian, B. Emami, K. Zafari and A. Bahreini-Moghadam, 2003a. Protection by sildenafil and theophylline of lead acetate-induced oxidative stress in rat submandibular gland and saliva. Hum. Exp. Toxicol., 22: 587-592.
3. Abdollahi, M., F. Soleimani and S. Kangarlou, 2003b. A review on blood glucose variations and affecting parameters. Middle East Pharmacy, 11: 6-10.
4. Abdollahi, M., T.S. Chan, V. Subrahmanyam and P.J. O'Brien, 2003c. Effects of phosphodiesterase 3,4,5 inhibitors on hepatocyte cAMP levels, glycogenolysis, gluconeogenesis and susceptibility to a mitochondrial toxin. Mol. Cell Biochem., 252: 205-211.
5. Abdollahi, M., M. Donyavi, S., Pournourmohammadi and M. Saadat, 2004a. Hyperglycemia associated with increased hepatic glycogen phosphorylase and phosphoenolpyruvate carboxykinase in rats following subchronic exposure to malathion. Comp. Biochem. Physiol. C Toxicol. Pharmacol., 137: 343-347.
6. Abdollahi, M., A. Ranjbar, S. Shadnia, S. Nikfar and A. Rezaiee, 2004b. Pesticides and oxidative stress. Med. Sci. Monit., 10: RA144-RA147.
7. Aghababaeian, R., M. Ghazi-Khansari, K. Abdi, F. Taghadosinejad and M. Abdollahi, 2005. Protective effects of sildenafil and dipyridamol from lead-induced lipid peroxidation in perfused rat liver. Intl. J. Phamacol., 1: 157-160.
8. Astaneie, F., M. Afshari, A. Mojtahedi, S. Mostafalou, M.J. Zamani, B. Larijani, M. Abdollahi, 2005. Total antioxidant capacity and levels of epidermal growth factor and nitric oxide in blood and saliva of insulin-dependent diabetic patients. Arch. Med. Res., 36: 376-381.
9. Atefi, M., S. Ghazanfari, S.N. Ostad, M.H. Ghahremani and M. Abdollahi, 2004. Alteration of glucose homeostasis by rolipram and milrinone but not sildenafil in rat primary hepatocytes culture. Prog. Med. Res., 2: 1-12.
10. Aydin, A., H. Orhan, A. Sayal, M. Ozata, G. Sahin and A. Isimer, 2001. Oxidative stress and nitric oxide related parameters in type II diabetes mellitus: Effects of glycemic control. Clin. Biochem., 34: 65-70.
11. Ballard, S.A., C.J. Gingell, K. Tang, L.A. Turner, M.E. Price and A.M. Naylor, 1998. Effects of sildenafil on the relaxation of human corpus cavernosum tissue in vitro and on the activities of cyclic nucleotide phosphodiesterase isozymes. J. Urol., 159: 2164-2171.
12. Barford, D. and L.N. Johnson, 1989. The allosteric transition of glycogen phosphorylase. Nature, 340: 609-616.
13. Bergmeyer, H.U., E. Bernt, F. Schmidt and H. Stork, 1974. D-glucose. In: Bergmeyer, H.U. (Edn.) Methods of Enzymatic Analysis, Vol. 3 Academic. Press. New. York, pp: 1196-1201.
14. Bollen, M., S. Keppens and W. Stalmans, 1998. Specific features of glycogen metabolism in the liver. Biochem. J., 336: 19-31.
15. Casado, M., M.J. Diaz-Guerra, L. Bosca and P. Martin-Sanz, 1997. Differential regulation of nitric oxide synthase mRNA xpression by lipopolysaccharide and pro-inflammatory cytokines in fetal hepatocytes treated with cycloheximide. Biochem. J., 327: 819-823.
16. Ceppi, E.D. and M.A. Titheradge, 1998. The importance of nitric oxide in the cytokine-induced inhibition of glucose formation by cultured hepatocytes incubated with insulin, dexamethasone and glucagon. Arch. Biochem. Biophys., 349: 167-174.
17. Chang, H.C. and M.D. Lane, 1966. The enzymatic carboxylation of phosphoenolpyruvate. II. Purification and properties of liver mitochondrial phosphoenolpyruvate carboxykinase. J. Biol. Chem., 241: 2413-2420.
18. Cidad, P., A. Almeida and J.P. Bolanos, 2004. Inhibition of mitochondrial respiration by nitric oxide rapidly stimulates cytoprotective GLUT3-mediated glucose uptake through 5′-AMP-activated protein kinase. Biochem. J., 384: 629-636.
19. Cosic, V., S. Antic, M. Pesic, O. Jovanovic, S. Kundalic and V.B. Djordjevic, 2001. Monotherapy with metformin: does it improve hypoxia in type 2 diabetic patients? Clin. Chem. Lab. Med., 39: 818-821.
20. Czech, M.P., 1977. Molecular basis of insulin action. Ann. Rev. Biochem., 46: 359-384.
21. Dal-Piaz, V. and M.P. Giovannoni, 2000. Phosphodiesterase 4 inhibitors, structurally unrelated to rolipram, as promising agents for the treatment of asthma and other pathologies. Eur. J. Med. Chem., 35: 463-480.
22. Davies, G.F., R.L. Khandelwal, L. Wu, B.H. Juurlink and W.J. Roesler, 2001. Inhibition of phosphoenolpyruvate carboxykinase (PEPCK) gene expression by troglitazone: A peroxisome proliferator-activated receptor-gamma (PPARgamma)-independent, antioxidant-related mechanism. Biochem. Pharmacol., 62: 1071-1079.
23. Foufelle, F. And P. Ferré, 2002. New perspectives in the regulation of hepatic glycolytic and lipogenic genes by insulin and glucose: A role for the transcription factor sterol regulatory element binding protein-1c. Biochem. J., 366: 377-391.
24. Jahanshahi, G., V. Motavasel, A. Rezaie, A.A. Hashtroudi, N.E. Daryani and M. Abdollahi, 2004. Alterations in antioxidant power and levels of epidermal growth factor and nitric oxide in saliva of patients with inflammatory bowel diseases. Dig. Dis. Sci., 49: 1752-1757.
25. Kahn, N.N., K. Acharya, S. Bhattacharya, R. Acharya, S. Mazumder, W.A. Bauman and A.K. Sinha, 2000. Nitric oxide: The second messenger of insulin. IUBMB Life, 49: 441-450.
26. Khan, N.N. and A.K. Sinha 1990. Stimulation of prostaglandin E1 binding to human platelet membrane by insulin and the activation of adenylate cyclase. J. Biom. Chem., 265: 4976-4981.
27. Koupparis, A.J., J.Y. Jeremy, S. Muzaffar, R. Persad and N. Shukla, 2005. Sildenafil inhibits the formation of superoxide and the expression of gp47 NAD(P)H oxidase induced by the thromboxane A2 mimetic, U46619, in corpus cavernosal smooth muscle cells. BJU. Intl., 96: 423-427.
28. Lowry, O.H., D.W. Schulz and J.V. Passonneau, 1967. The kinetics of glycogen phosphorylases from brain and muscle. J. Biol. Chem., 242: 271-280.
29. Lowry, O.H., N.J. Roserbrough, A.L. Farr and R.J. Randell, 1951. Protein measurement with the folin phenol reagent. J. Biol., Chem., 193: 265-275.
30. Mahajan, H., S.M. Richards, S. Rattigan and M.G. Clark, 2003. T-1032, a cyclic GMP phosphodiesterase-5 inhibitor, acutely blocks physiologic insulin-mediated muscle haemodynamic effects and glucose uptake in vivo. Br. J. Pharmacol., 140: 1283-1291.
31. Milani, E., S. Nikfar, R. Khorasani, M.J. Zamani and M. Abdollahi, 2005. Reduction of diabetes-induced oxidative stress by phosphodiesterase inhibitors in rats. Comp. Biochem. Physiol. C Toxicol. Pharmacol., 140: 251-255.
32. Nordlie, R.C., J.D. Foster and A.J. Lange, 1999. Regulation of glucose production by the liver. Ann. Rev. Nutr., 19: 379-406.
33. Parker, J.C., M.A. Van Volkenburg, N.A. Nardone, D.M. Hargrove and K.M. Andrews, 1997. Modulation of insulin secretion and glycemia by selective inhibition of cyclic AMP phosphodiesterase III. Biochem. Biophys. Res. Commun., 236: 665-669.
34. 2+ in the regulation of glycogenolysis in rat liver cells. J. Biol. Chem., 251: 2987-2992.
35. Radfar, M., B. Larijani, M. Hadjibabaie, B. Rajabipour, A. Mojtahedi and M. Abdollahi, 2005. Effects of pentoxifylline on oxidative stress and levels of EGF and NO in blood of diabetic type-2 patients; a randomized, double-blind placebo-controlled clinical trial. Biomed. Pharmacoth., 59: 302-306.
36. Rahimi, R., S. Nikfar, B. Larijani and M. Abdollahi, 2005. A review on the role of antioxidants in the management of diabetes and its complications. Biomed. Pharmacother., 59: 365-373.
37. Saadat, M., S. Pournourmohammadi, M. Donyavi, R. Khorasani, G. Amin, A.N. Salehnia and M. Abdollahi, 2004. Alteration of rat hepatic glycogen phosphorylase and phosphoenolpyruvate carboxykinase activities by Satureja khuzestanica Jamzad essential oil. J. Pharm. Pharm. Sci., 7: 310-314.
38. Shukla, N., R. Jones, R. Persad, G.D. Angelini and J.Y. Jeremy, 2005. Effect of sildenafil citrate and a nitric oxide donating sildenafil derivative, NCX 911, on cavernosal relaxation and superoxide formation inhypercholesterolaemic rabbits. Eur. J. Pharmacol., 517: 224-31.
39. Soderling, S.H. and J.A. Beavo, 2000. Regulation of cAMP and cGMP signaling: New phosphodiesterases and new functions. Curr. Opin. Cell. Biol. Rev., 12: 174-179.
40. Souness, J.E., D. Aldous and C. Sargent, 2000. Immunosuppressive and anti-inflammatory effects of cyclic AMP phosphodiesterase (PDE) type 4 inhibitors. Immunopharmacol. Rev., 47: 127-162.
41. Stadler, J., D. Barton, H. Beil-Moeller, S. Diekmann, C. Hierholzer, W. Erhard and C.D. Heidecke, 1995. Hepatocyte nitric oxide biosynthesis inhibits glucose output and competes with urea synthesis for L-arginine. Am. J. Physiol., 268: G183-188.